Your browser doesn't support javascript.
loading
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study.
Kaya, Firat; Ernest, Jacqueline P; LoMauro, Katherine; Gengenbacher, Martin; Madani, Abdeldjalil; Aragaw, Wassihun Wedajo; Zimmerman, Matthew D; Sarathy, Jansy P; Alvarez, Nadine; Daudelin, Isaac; Wang, Han; Lanni, Faye; Weiner, Danielle M; Via, Laura E; Barry, Clifton E; Olivier, Kenneth N; Dick, Thomas; Podell, Brendan K; Savic, Radojka M; Dartois, Véronique.
Afiliação
  • Kaya F; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Ernest JP; Department of Bioengineering and Therapeutic Sciences, University of California, San Franciscogrid.266102.1, San Francisco, California, USA.
  • LoMauro K; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Gengenbacher M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Madani A; Hackensack Meridian School of Medicine, Department of Medical Sciences, Nutley, New Jersey, USA.
  • Aragaw WW; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Zimmerman MD; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Sarathy JP; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Alvarez N; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Daudelin I; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Wang H; New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Lanni F; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Weiner DM; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Via LE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Maryland, USA.
  • Barry CE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Maryland, USA.
  • Olivier KN; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, Cape Town, South Africa.
  • Dick T; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Maryland, USA.
  • Podell BK; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, Cape Town, South Africa.
  • Savic RM; Laboratory of Chronic Airway Infection, Pulmonary Branch, National Hearth Lung Blood Institute, NIH, Bethesda, Maryland, USA.
  • Dartois V; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Antimicrob Agents Chemother ; 66(3): e0221221, 2022 03 15.
Article em En | MEDLINE | ID: mdl-35099272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumopatias / Infecções por Mycobacterium não Tuberculosas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumopatias / Infecções por Mycobacterium não Tuberculosas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos